Cellics Therapeutics, Inc. — Form D/A
Cellics Therapeutics, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2017-04-21. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-04-21
- Form: D/A
- Accession: 0001611752-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Investors: 1
- Date of first sale: 2016-02-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-256953
Issuer
- Name: Cellics Therapeutics, Inc.
- CIK: 0001611752
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11588 Sorrento Valley Road, San Diego, CA, 92121
- Phone: 858-412-6148
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Dai Jimming | Director | San Diego, CA |
| Jie Zhang | Director | San Diego, CA |
| Jie Zhang | Executive Officer | San Diego, CA |
| Liangfang Zhang | Director | San Diego, CA |
| Huiqing Zhu | Director | San Diego, CA |
| Huiqing Zhu | Executive Officer | San Diego, CA |
| Wei Shen | Director | San Diego, CA |
| Cihui Li | Director | San Diego, CA |
| Angela Fang Chen | Director | San Diego, CA |
| Lili Xie | Director | San Diego, CA |
| Lili Xie | Executive Officer | San Diego, CA |
| Dai Jinming | Director | San Diego, CA |
| Weiwei Gao | Director | San Diego, CA |
Other filings by this issuer (4)
More